Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

Marianne Abifadel1, Mathilde Varret, Jean-Pierre Rabès

  • 1INSERM U383, Hôpital Necker-Enfants Malades, AP-HP, Université Paris V, 149-161 rue de Sèvres, 75743 Paris Cedex 15, France.

Nature Genetics
|May 6, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dosage compensation and meiotic sex chromosome inactivation are maintained under relaxed selection.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Global population structure in MAST-4 unicellular marine predators.

Communications biology·2026
Same author

DNA transposon expansion drives genome plasticity in Diutina catenulata.

Nature communications·2026
Same author

Author Correction: Magnetoreception in a freshwater ciliate arises from endosymbiosis.

Nature communications·2026
Same author

Unveiling plastic biodegradation pathways through <sup>13</sup>C-DNA stable isotope probing and metagenomics.

Journal of hazardous materials·2026
Same author

ERGA-BGE reference genome of <i>Diadema setosum:</i> the Black Longspine Urchin invading the Mediterranean sea.

Open research Europe·2026

Autosomal dominant hypercholesterolemia (ADH) is linked to mutations in LDLR or APOB genes. Researchers discovered two new mutations in the PCSK9 gene causing ADH, impacting cholesterol levels.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiovascular Disease Research

Background:

  • Autosomal dominant hypercholesterolemia (ADH) elevates low-density lipoprotein cholesterol, a significant coronary heart disease risk factor.
  • Mutations in LDLR and APOB genes are established causes of ADH.
  • A third genetic locus, HCHOLA3 at 1p32, was previously associated with ADH.

Purpose of the Study:

  • To identify the genetic basis of ADH linked to the HCHOLA3 locus.
  • To investigate the role of the PCSK9 gene in autosomal dominant hypercholesterolemia.

Main Methods:

  • Genetic linkage analysis to map the HCHOLA3 locus.
  • Mutation screening of the PCSK9 gene in patients with ADH.
  • Analysis of PCSK9 gene expression and function.

Related Experiment Videos

Main Results:

  • Two distinct mutations in the PCSK9 gene were identified in individuals with ADH.
  • PCSK9 encodes a novel human subtilase, NARC-1, highly expressed in the liver.
  • PCSK9 plays a role in regulating cholesterol homeostasis.

Conclusions:

  • Mutations in the PCSK9 gene are a newly identified cause of autosomal dominant hypercholesterolemia.
  • PCSK9 is implicated in cholesterol metabolism and cardiovascular disease risk.
  • Discovery of PCSK9 mutations expands the genetic understanding of hypercholesterolemia.